Burkina Faso vs Burundi: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Burkina Faso
- Burundi
How they compare
Burundi currently reports 4,624 deaths against 4,383 deaths in Burkina Faso, a difference of 241 deaths.
That makes Burundi's figure about 1.1 times Burkina Faso's.
The two have swapped places 4 times across 35 shared years of data; in 1990 it was Burundi ahead.
Burkina Faso ranks 41st and Burundi ranks 39th of 157 countries.
Across the 4 decades both report, Burkina Faso averaged higher in 2 and Burundi in 1.
Head to head by decade
| Decade | Burkina Faso | Burundi | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,688 deaths | 1,207 deaths | 480.11 deaths | Burkina Faso |
| 2010s | 4,403 deaths | 4,004 deaths | 398.89 deaths | Burkina Faso |
| 2020s | 4,350 deaths | 4,704 deaths | 353.58 deaths | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Burkina Faso or Burundi?
- Burundi, at 4,624 deaths against 4,383 deaths in Burkina Faso as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Burkina Faso and Burundi?
- 241 deaths, with Burundi ahead.
- How many years of comparable data are there for Burkina Faso and Burundi?
- 35 years are reported by both, from 1990 to 2024.
- How do Burkina Faso and Burundi rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Burkina Faso ranks 41st and Burundi ranks 39th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.